
Last updated: 2026-10-15 08:14:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cellyan Biotechnology Co., Ltd (HKPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.11, with a market capitalization of $5.17M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.10 to $1.72. This page covers its latest market performance, valuation, price trends and company information.
$5.17M | |
$0.11 | |
$3.79 | |
$0.10 | |
$0.11 | |
156.00 | |
3.79M | |
-- | |
$1.72 | |
$0.10 | |
-- | |
-- |
Cellyan Biotechnology Co., Ltd (HKPD) is trading at $0.11 in pre-market trading as of 2026-10-15 08:05:00, down 7.08% ($0.01) from the previous close of $0.11
Pre-market trading shows how investors are pricing HKPD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Cellyan Biotechnology Co., Ltd (HKPD) moved from $0.10 to $0.11, representing a gain of 2.04% ($0.00).
The stock traded between $0.10 and $0.11 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 362.06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.6%
HKPD is currently trading at $0.11, placing it 0.6% of the way from its 52-week low of $0.10 to its 52-week high of $1.72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellyan Biotechnology Co., Ltd (HKPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.